SCHEMBL6971201

SCHEMBL6971201

COCCC[Si](C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6972099 0.91 ALDH1A1 (0.37)
SCHEMBL6965634 0.88 ALDH1A1 (0.41)
SCHEMBL15297875 0.88 ALDH1A1 (0.41)
SCHEMBL1104617 0.84 ALOX15 (0.34)
SCHEMBL16978083 0.84 ALOX15 (0.34)
SCHEMBL4226846 0.84 ALOX15 (0.34)
SCHEMBL8009 0.80
SCHEMBL9332388 0.78 ALOX15 (0.39)
Hydrochloric Acid SCHEMBL866240 0.78
Ammonia Solution, Strong SCHEMBL16110998 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117739798-B Preparation method of flexible resistance type strain sensor, prepared flexible resistance type strain sensor and application of flexible resistance type strain sensor 暨南大学 2024-05-07 CN disclosed
CN-117739798-A Preparation method of flexible resistance type strain sensor, prepared flexible resistance type strain sensor and application of flexible resistance type strain sensor 暨南大学 2024-03-22 CN disclosed
US-9917328-B2 Halogenated organosilicon electrolytes, methods of using them, and electrochemical devices containing them SILATRONIX, INC. (US) 2018-03-13 US disclosed
US-20170037050-A1 ISOQUINOLINESULFONYL DERIVATIVE AS RHO KINASE INHIBITOR MEDSHINE DISCOVERY INC. (CN) 2017-02-09 US disclosed
US-9505739-B2 Spiropyrrolidine beta-secretase inhibitors for the treatment of alzheimer's disease MERCK SHARP & DOHME CORP. (US) 2016-11-29 US disclosed
US-9163012-B2 Carbamate and urea inhibitors of 11β-hydroxysteroid dehydrogenase 1 VITAE PHARMACEUTICALS, INC. (US) 2015-10-20 US disclosed
US-20150270573-A1 HALOGENATED ORGANOSILICON ELECTROLYTES, METHODS OF USING THEM, AND ELECTROCHEMICAL DEVICES CONTAINING THEM SILATRONIX, INC. (US) 2015-09-24 US disclosed
US-20150038490-A1 SPIROPYRROLIDINE BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE MERCK SHARP & DOHME CORP. (US) 2015-02-05 US disclosed
US-20150037686-A1 HALOGENATED ORGANOSILICON ELECTROLYTES, METHODS OF USING THEM, AND ELECTROCHEMICAL DEVICES CONTAINING THEM ORBIA FLUOR & ENERGY MATERIALS USA, INC. 2015-02-05 US disclosed
US-8865701-B2 Spiropyrrolidine beta-secretase inhibitors for the treatment of alzheimer'S disease MERCK SHARP & DOHME CORP. (US) 2014-10-21 US disclosed
US-8329770-B2 Silicon-containing foams WACKER CHEMIE AG (DE) 2012-12-11 US disclosed
US-20120208820-A1 DIAZABICYCLIC CENTRAL NERVOUS SYSTEM ACTIVE AGENTS SCHRIMPF MICHAEL R (US) 2012-08-16 US disclosed
US-20110306595-A1 SPIROPYRROLIDINE BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE MERCK SHARP & DOHME LLC 2011-12-15 US disclosed
US-20110053943-A1 CARBAMATE AND UREA INHIBITORS OF 11ß-HYDROXYSTEROID DEHYDROGENASE 1 VITAE PHARMACEUTICALS, INC. 2011-03-03 US disclosed
US-20100305229-A1 SILICON-CONTAINING FOAMS WACKER CHEMIE AG (DE) 2010-12-02 US disclosed
US-20100292428-A1 Highly Porous Ceramic Oxide Aerogels Having Improved Flexibility OHIO AEROSPACE INSTITUTE (US) 2010-11-18 US disclosed
US-20090105358-A1 SILICONE-CONTAINING FOAMS WACKER CHEMIE AG (DE) 2009-04-23 US disclosed
US-20080051482-A1 Foams Containing Silicon CONSORTIUM FUER ELEKTROCHEMISCHE INDUSTRIE GMBH (DE) 2008-02-28 US disclosed
US-20070231671-A1 Catalyst Material For Use In Fuel Cell, Catalyst Membrane, Membrane Electrode Assembly and Fuel Cell FUJIFILM CORPORATION 2007-10-04 US disclosed
EP-1329160-A2 4-ACYLAMINOPYRAZOLE DERIVATIVES Sankyo Company, Limited (JP) 2003-07-23 EP disclosed